MAPK3 and cancer: Studies have shown that CLCF1 produced by CAFs can stimulate TGF-β1 and CXCL6 secretion by cancer cells, thereby increasing the stemness of cancer cells and activating the ERK1/2 signaling pathway in CAFs.